Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, preventing access to the study record. The previously visible trial details and sponsor information are no longer accessible on this page.
    Difference
    21%
    Check dated 2026-09-24T18:07:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new published revision of the study details page.
    Difference
    0.0%
    Check dated 2026-09-17T21:50:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This appears to be a minor backend/CMS patch with no changes to study content or patient-facing information.
    Difference
    0.0%
    Check dated 2026-09-03T13:53:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    NIH grant/contract funding lines for 2019 and 2023 were added to the study record to reflect the funding sources.
    Difference
    0.1%
    Check dated 2026-08-27T11:11:13.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page as a new version identifier. The Plain Language Summary and Revision: v3.6.4 have been removed, indicating a small administrative update to the study documentation.
    Difference
    0.1%
    Check dated 2026-08-13T01:57:35.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page shows updated and removed date entries (e.g., 2026-07-30, 2026-08-21, 2026-07-28, 2026-07) indicating maintenance timestamps rather than changes to the study content.
    Difference
    0.2%
    Check dated 2026-08-06T00:19:21.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.